Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PATE-G Inhibitors

PATE-G inhibitors are a class of chemical compounds that function by targeting and inhibiting the activity of the PATE-G protein. This protein is part of the PATE (Prostate And Testis Expressed) family, which is known for its role in various cellular processes, including cellular signaling and protein interactions. The inhibition of PATE-G involves intricate mechanisms at the molecular level, where inhibitors typically bind to specific active sites on the PATE-G protein, thereby altering its conformation and function. These inhibitors are designed to interact with the protein's specific structural features, including binding pockets and catalytic domains, which are crucial for its biological activity.

The development and study of PATE-G inhibitors involve advanced techniques in molecular biology and chemistry, such as structure-based drug design, molecular docking studies, and high-throughput screening. Researchers employ these techniques to identify potential inhibitory compounds and optimize their efficacy and selectivity. Additionally, the synthesis of PATE-G inhibitors often requires sophisticated organic chemistry methods to achieve the desired molecular structures and functionalities. This chemical class is characterized by a diverse range of molecular scaffolds and functional groups, which are tailored to achieve high binding affinity and specificity for the PATE-G protein. The ongoing research into PATE-G inhibitors continues to reveal new insights into their molecular interactions and potential applications in scientific research.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

MEK inhibitor, may modify MAPK/ERK pathway, potentially intersecting with PATE-G's role in cell signaling and proliferation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor, could affect cell growth and survival pathways, potentially linked to PATE-G's function.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

CDK4/6 inhibitor; might affect cell cycle regulation, potentially intersecting with PATE-G's role in cell proliferation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor; could affect protein degradation pathways, potentially linked to PATE-G's function.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

RAF kinase inhibitor; might influence cell signaling pathways where PATE-G is implicated, particularly in cell growth.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

BCR-ABL tyrosine kinase inhibitor; may influence cell proliferation pathways, possibly intersecting with PATE-G.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$75.00
$121.00
33
(1)

EGFR inhibitor, could impact pathways intersecting with PATE-G's function in cell growth and proliferation.